Search Results
The ACE-LY-004 study of acalabrutinib monotherapy for mantle cell lymphoma
Long-term follow-up of acalabrutinib in R/R mantle cell lymphoma
Acalabrutinib for Treating Mantle Cell Lymphoma
Acalabrutinib in Relapsed Mantle Cell Lymphoma
Approval of Acalabrutinib in Mantle Cell Lymphoma
Dr. Goy on Acalabrutinib Versus Ibrutinib in MCL
Dr. Shah Discusses Sequencing for MCL
ASH 2017: Acalabrutinib Therapy for R/R Mantle Cell Lymphoma
A novel WINDOW of opportunity for young mantle cell lymphoma patients
BTK Inhibitors in Mantle Cell Lymphoma
Dr. Logan Discusses Acalabrutinib in CLL
Dr. Gerson on Clinical Trial Accrual in MCL